These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2997488)

  • 21. Development of a turbidimetric assay to study the effect of urinary components on calcium oxalate precipitation.
    Saso L; Valentini G; Casini ML; Mattei E; Panzironi C; Silvestrini B
    Urol Int; 1998; 60(1):47-52. PubMed ID: 9519421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
    Williams G; Sallis JD
    Calcif Tissue Int; 1982 Mar; 34(2):169-77. PubMed ID: 6282411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Ohkawa T
    Urol Int; 1987; 42(5):330-7. PubMed ID: 3433579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Introduction of an enzyme method for determining pyrophosphate in urine--a comparative study between patients with calculi and normal probands].
    Genester C; Salgado J; Coll R; Conte A; Grases F
    Z Urol Nephrol; 1989 Jul; 82(7):369-73. PubMed ID: 2549749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of calcium phosphate inhibitor activity. Critical assessment of the methodology.
    Meyer JL; Fleisch H
    Miner Electrolyte Metab; 1984; 10(4):249-58. PubMed ID: 6087103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of sodium citrate and oral potassium citrate on urease-induced crystallization.
    Wang YH; Grenabo L; Hedelin H; Pettersson S
    Br J Urol; 1994 Oct; 74(4):409-15. PubMed ID: 7820416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of citrate and urinary macromolecules on the aggregation of hydroxyapatite crystals in solutions with a composition similar to that in the distal tubule.
    Højgaard I; Tiselius HG
    Urol Res; 1998; 26(2):89-95. PubMed ID: 9631940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seeded growth of hydroxyapatite in the presence of dissolved albumin.
    Gilman H; Hukins DW
    J Inorg Biochem; 1994 Jul; 55(1):21-30. PubMed ID: 8046435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrophosphate adsorption onto hydroxyapatite and its inhibition of crystal growth.
    Moreno EC; Aoba T; Margolis HC
    Compend Suppl; 1987; (8):S256-8, S260, S262-6. PubMed ID: 3036354
    [No Abstract]   [Full Text] [Related]  

  • 39. The inhibitory effects of ATP, ADP, and AMP on the rate of dissolution of calcium hydroxyapatite.
    Christoffersen MR; Christoffersen J
    Calcif Tissue Int; 1984 Dec; 36(6):659-61. PubMed ID: 6099210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Escherichia coli on urine citrate and urease-induced crystallization.
    Edin-Liljegren A; Hedelin HH; Grenabo L; Pettersson S
    Scanning Microsc; 1995 Sep; 9(3):901-5. PubMed ID: 7501998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.